Published in Stem Cells on May 01, 2010
Functional consequences of developmentally regulated alternative splicing. Nat Rev Genet (2011) 3.27
HIF induces human embryonic stem cell markers in cancer cells. Cancer Res (2011) 2.46
Newer insights into premeiotic development of germ cells in adult human testis using Oct-4 as a stem cell marker. J Histochem Cytochem (2010) 1.92
Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. J Biol Chem (2012) 1.57
OCT4 establishes and maintains nucleosome-depleted regions that provide additional layers of epigenetic regulation of its target genes. Proc Natl Acad Sci U S A (2011) 1.51
Stem cells, progenitors & regenerative medicine: A retrospection. Indian J Med Res (2015) 1.48
Role of Oct4 in maintaining and regaining stem cell pluripotency. Stem Cell Res Ther (2010) 1.12
Inhibition of platelet-derived growth factor receptor signaling regulates Oct4 and Nanog expression, cell shape, and mesenchymal stem cell potency. Stem Cells (2012) 1.09
Evolutionary history and genome organization of DUF1220 protein domains. G3 (Bethesda) (2012) 1.08
Murine bone marrow Lin⁻Sca⁻1⁺CD45⁻ very small embryonic-like (VSEL) cells are heterogeneous population lacking Oct-4A expression. PLoS One (2013) 1.07
Very small embryonic-like stem cells: implications in reproductive biology. Biomed Res Int (2013) 1.07
Specific detection of OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3/4 specificity for germ cell tumours. Br J Cancer (2011) 1.05
Are Mesenchymal Cells Indeed Pluripotent Stem Cells or Just Stromal Cells? OCT-4 and VSELs Biology Has Led to Better Understanding. Stem Cells Int (2013) 1.05
Pluripotency transcription factors and cancer stem cells: small genes make a big difference. Chin J Cancer (2013) 1.02
Attributes of Oct4 in stem cell biology: perspectives on cancer stem cells of the ovary. J Ovarian Res (2012) 1.02
Three steps to the immortality of cancer cells: senescence, polyploidy and self-renewal. Cancer Cell Int (2013) 1.01
Downregulation of KPNA2 in non-small-cell lung cancer is associated with Oct4 expression. J Transl Med (2013) 1.01
False-positive antibody signals for the pluripotency factor OCT4A (POU5F1) in testis-derived cells may lead to erroneous data and misinterpretations. Mol Hum Reprod (2012) 1.00
Stem cell interaction with somatic niche may hold the key to fertility restoration in cancer patients. Obstet Gynecol Int (2012) 0.93
Delineation of breast cancer cell hierarchy identifies the subset responsible for dormancy. Sci Rep (2012) 0.92
The differential expression of OCT4 isoforms in cervical carcinoma. PLoS One (2015) 0.89
Differential transcript isoform usage pre- and post-zygotic genome activation in zebrafish. BMC Genomics (2013) 0.86
Akt‑mediated phosphorylation of Oct4 is associated with the proliferation of stem‑like cancer cells. Oncol Rep (2015) 0.85
Expression and differentiation between OCT4A and its Pseudogenes in human ESCs and differentiated adult somatic cells. PLoS One (2014) 0.85
Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites. BMC Cancer (2012) 0.83
Preoperative low dose NSAID treatment influences the genes for stemness, growth, invasion and metastasis in colorectal cancer. Int J Oncol (2014) 0.83
OCT4 as a target of miR-34a stimulates p63 but inhibits p53 to promote human cell transformation. Cell Death Dis (2014) 0.83
Intricacies of Pluripotency. J Stem Cells Regen Med (2015) 0.82
A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer. Mol Cancer (2015) 0.81
Alternative splicing: An important mechanism in stem cell biology. World J Stem Cells (2015) 0.81
Aberrant promoter methylation and expression of UTF1 during cervical carcinogenesis. PLoS One (2012) 0.81
Gestational stage affects amniotic epithelial cells phenotype, methylation status, immunomodulatory and stemness properties. Stem Cell Rev (2014) 0.80
Induced pluripotent stem cells: Mechanisms, achievements and perspectives in farm animals. World J Stem Cells (2015) 0.80
Primordial germ cell development in the marmoset monkey as revealed by pluripotency factor expression: suggestion of a novel model of embryonic germ cell translocation. Mol Hum Reprod (2014) 0.80
Identification of small activating RNAs that enhance endogenous OCT4 expression in human mesenchymal stem cells. Stem Cells Dev (2014) 0.80
A therapy-grade protocol for differentiation of pluripotent stem cells into mesenchymal stem cells using platelet lysate as supplement. Stem Cell Res Ther (2015) 0.80
Molecular and phenotypic characterization of CD133 and SSEA4 enriched very small embryonic-like stem cells in human cord blood. Leukemia (2015) 0.80
OCT4 pseudogenes present in human leukemia cells. Clin Exp Med (2011) 0.79
Differential Expression of OCT4 Pseudogenes in Pluripotent and Tumor Cell Lines. Cell J (2016) 0.78
The neonatal marmoset monkey ovary is very primitive exhibiting many oogonia. Reproduction (2014) 0.78
Expression of mesenchymal stem cells-related genes and plasticity of aspirated follicular cells obtained from infertile women. Biomed Res Int (2014) 0.78
Upregulation of pluripotency markers in adipose tissue-derived stem cells by miR-302 and leukemia inhibitory factor. Biomed Res Int (2014) 0.78
Alternative splicing in self-renewal of embryonic stem cells. Stem Cells Int (2011) 0.78
Human Amniocytes Are Receptive to Chemically Induced Reprogramming to Pluripotency. Mol Ther (2017) 0.77
Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodelling. Sci Rep (2017) 0.77
Very small embryonic-like stem cells are the elusive mouse endometrial stem cells--a pilot study. J Ovarian Res (2015) 0.77
Putative mesenchymal stem cells isolated from adult human ovaries. J Assist Reprod Genet (2014) 0.77
Coalition of Oct4A and β1 integrins in facilitating metastasis in ovarian cancer. BMC Cancer (2016) 0.76
Markers of Pluripotency in Human Amniotic Epithelial Cells and Their Differentiation to Progenitor of Cortical Neurons. PLoS One (2015) 0.76
Alternative splicing acting as a bridge in evolution. Stem Cell Investig (2015) 0.76
Mechanisms of Immune Suppression Utilized by Canine Adipose and Bone Marrow-Derived Mesenchymal Stem Cells. Stem Cells Dev (2016) 0.75
Clinicopathological and prognostic significance of Oct-4 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis. J Thorac Dis (2016) 0.75
The novel function of Oct3/4 in mouse tooth development. Histochem Cell Biol (2011) 0.75
Effect of dynamic DNA methylation and histone acetylation on cPouV expression in differentiation of chick embryonic germ cells. Stem Cells Dev (2013) 0.75
Glutamine contributes to maintenance of mouse embryonic stem cell self-renewal through PKC-dependent downregulation of HDAC1 and DNMT1/3a. Cell Cycle (2015) 0.75
Cancer stem cells (CSCs), cervical CSCs and targeted therapies. Oncotarget (2017) 0.75
Evolutionary Conservation of pou5f3 Genomic Organization and Its Dynamic Distribution during Embryogenesis and in Adult Gonads in Japanese Flounder Paralichthys olivaceus. Int J Mol Sci (2017) 0.75
High OCT4A levels drive tumorigenicity and metastatic potential of medulloblastoma cells. Oncotarget (2017) 0.75
Comparative In Vitro Evaluation of Human Dental Pulp and Follicle Stem Cell Commitment. Cell J (2016) 0.75
Changes in the expression of OCT4 in mouse ovary during estrous cycle. Vet Res Forum (2017) 0.75
Human dental pulp pluripotent-like stem cells promote wound healing and muscle regeneration. Stem Cell Res Ther (2017) 0.75
TGFβ-induced osteogenic potential of human amniotic fluid stem cells via CD73-generated adenosine production. Sci Rep (2017) 0.75
A Novel Variant of OCT4 Entitled OCT4B3 is Expressed in Human Bladder Cancer and Astrocytoma Cell Lines. Avicenna J Med Biotechnol (2017) 0.75
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Induced pluripotent stem cell lines derived from human somatic cells. Science (2007) 71.50
Core transcriptional regulatory circuitry in human embryonic stem cells. Cell (2005) 34.93
Reprogramming of human somatic cells to pluripotency with defined factors. Nature (2007) 30.84
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature (2007) 28.24
A chromatin landmark and transcription initiation at most promoters in human cells. Cell (2007) 23.41
Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet (2000) 21.52
Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell (1998) 19.05
Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell (2008) 10.34
Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell (2005) 9.84
A protein interaction network for pluripotency of embryonic stem cells. Nature (2006) 9.63
Effects of primer-template mismatches on the polymerase chain reaction: human immunodeficiency virus type 1 model studies. Nucleic Acids Res (1990) 9.28
Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol (2007) 9.04
Role of the murine reprogramming factors in the induction of pluripotency. Cell (2009) 7.46
Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells. Genes Dev (2007) 5.79
A fresh look at iPS cells. Cell (2009) 5.73
Oct4 expression is not required for mouse somatic stem cell self-renewal. Cell Stem Cell (2007) 5.29
Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells (2001) 4.63
Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell (2003) 4.50
Direct reprogramming of human neural stem cells by OCT4. Nature (2009) 4.32
The transcriptome profile of human embryonic stem cells as defined by SAGE. Stem Cells (2004) 3.78
Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis (2004) 3.66
Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science (2000) 3.63
Oct-4 knockdown induces similar patterns of endoderm and trophoblast differentiation markers in human and mouse embryonic stem cells. Stem Cells (2004) 3.55
The POU domain: versatility in transcriptional regulation by a flexible two-in-one DNA-binding domain. Genes Dev (1995) 2.97
The POU domain is a bipartite DNA-binding structure. Nature (1988) 2.92
Transcribed processed pseudogenes in the human genome: an intermediate form of expressed retrosequence lacking protein-coding ability. Nucleic Acids Res (2005) 2.89
Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation. Proc Natl Acad Sci U S A (2009) 2.86
Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer (2005) 2.84
High-efficiency RNA interference in human embryonic stem cells. Stem Cells (2005) 2.76
Oct4 is required for primordial germ cell survival. EMBO Rep (2004) 2.56
Specific knockdown of Oct4 and beta2-microglobulin expression by RNA interference in human embryonic stem cells and embryonic carcinoma cells. Stem Cells (2004) 2.52
Alternative initiation of translation determines cytoplasmic or nuclear localization of basic fibroblast growth factor. Mol Cell Biol (1991) 2.47
POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res (2003) 2.45
The pluripotency factor Oct4 interacts with Ctcf and also controls X-chromosome pairing and counting. Nature (2009) 2.40
Oct-4 expression in adult human differentiated cells challenges its role as a pure stem cell marker. Stem Cells (2007) 2.39
Oct4 pseudogenes are transcribed in cancers. Biochem Biophys Res Commun (2005) 2.34
Human embryonic genes re-expressed in cancer cells. Oncogene (2001) 2.26
OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma. Am J Surg Pathol (2004) 1.99
OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells. Stem Cells (2008) 1.95
Establishing a germ cell origin for metastatic tumors using OCT4 immunohistochemistry. Cancer (2004) 1.95
The human OCT-4 isoforms differ in their ability to confer self-renewal. J Biol Chem (2006) 1.94
Functional similarities among genes regulated by OCT4 in human mesenchymal and embryonic stem cells. Stem Cells (2007) 1.89
Oct4 and its pseudogenes confuse stem cell research. Cell Stem Cell (2007) 1.87
Multiple retropseudogenes from pluripotent cell-specific gene expression indicates a potential signature for novel gene identification. J Biol Chem (2005) 1.79
The pluripotency regulator Oct4: a role in somatic stem cells? Cell Cycle (2008) 1.79
Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis. Cancer Res (2008) 1.76
Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research. Biol Chem (2008) 1.72
OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer. Int J Cancer (2007) 1.68
Human Oct3 gene family: cDNA sequences, alternative splicing, gene organization, chromosomal location, and expression at low levels in adult tissues. Nucleic Acids Res (1992) 1.65
Targeting of a human iron-sulfur cluster assembly enzyme, nifs, to different subcellular compartments is regulated through alternative AUG utilization. Mol Cell (1998) 1.56
Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells. Cancer Res (2008) 1.55
Conserved and divergent patterns of expression of DAZL, VASA and OCT4 in the germ cells of the human fetal ovary and testis. BMC Dev Biol (2007) 1.49
OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. J Pathol (2007) 1.44
POU5F1 isoforms show different expression patterns in human embryonic stem cells and preimplantation embryos. Stem Cells (2006) 1.43
Absence of OCT4 expression in somatic tumor cell lines. Stem Cells (2007) 1.41
Developmental expression of POU5F1 (OCT-3/4) in normal and dysgenetic human gonads. Hum Reprod (2004) 1.34
Alternative translation of OCT4 by an internal ribosome entry site and its novel function in stress response. Stem Cells (2009) 1.33
Oct-4 mRNA and protein expression during human preimplantation development. Mol Hum Reprod (2005) 1.31
Oct4A is expressed by a subpopulation of prostate neuroendocrine cells. Prostate (2009) 1.25
The carboxy-terminal transactivation domain of Oct-4 acquires cell specificity through the POU domain. Mol Cell Biol (1997) 1.25
Expression of pluripotent stem cell markers in the human fetal testis. Stem Cells (2007) 1.24
Diagnostic value of OCT3/4 for pre-invasive and invasive testicular germ cell tumours. J Pathol (2005) 1.22
Oct-4 expression in inner cell mass and trophectoderm of human blastocysts. Mol Hum Reprod (2000) 1.20
Multipotent progenitor cells are present in human peripheral blood. Circ Res (2009) 1.20
Stem cell marker OCT3/4 in tumor biology and germ cell tumor diagnostics: history and future. Crit Rev Oncog (2006) 1.16
Identification of a nuclear localization signal in OCT4 and generation of a dominant negative mutant by its ablation. J Biol Chem (2004) 1.14
The POU5F1P1 pseudogene encodes a putative protein similar to POU5F1 isoform 1. Oncol Rep (2008) 1.09
Differential expression of the embryo/cancer gene ECSA(DPPA2), the cancer/testis gene BORIS and the pluripotency structural gene OCT4, in human preimplantation development. Mol Hum Reprod (2008) 1.08
OCT4A contributes to the stemness and multi-potency of human umbilical cord blood-derived multipotent stem cells (hUCB-MSCs). Biochem Biophys Res Commun (2009) 1.08
Common variants in 8q24 are associated with risk for prostate cancer and tumor aggressiveness in men of European ancestry. Prostate (2009) 1.08
Expression of transcription regulating genes in human preimplantation embryos. Hum Reprod (1995) 1.03
OCT4 immunohistochemistry is superior to placental alkaline phosphatase (PLAP) in the diagnosis of central nervous system germinoma. Am J Surg Pathol (2005) 1.02
Revisiting OCT4 expression in peripheral blood mononuclear cells. Stem Cells (2007) 0.98
Analysis of OCT4 expression in an extended panel of human tumor cell lines from multiple entities and in human mesenchymal stem cells. Cell Mol Life Sci (2009) 0.97
In vivo osteoprogenitor potency of human stromal cells from different tissues does not correlate with expression of POU5F1 or its pseudogenes. Stem Cells (2008) 0.96
Identification of genes expressed in human primordial germ cells at the time of entry of the female germ line into meiosis. Mol Hum Reprod (1999) 0.94
OCT4B1 isoform: the novel OCT4 alternative spliced variant as a putative marker of stemness. Mol Hum Reprod (2009) 0.91
Alteration of protein subcellular location and domain formation by alternative translational initiation. Proteins (2006) 0.89
Novel variants of Oct-3/4 gene expressed in mouse somatic cells. J Biol Chem (2008) 0.87
A PCR/restriction digestion assay for the detection of the transcript variants 1 and 2 of POU5F1. Genes Chromosomes Cancer (2008) 0.84
The expression of pluripotency marker Oct 3/4 in prostate cancer and benign prostate hyperplasia. Prostate (2009) 0.84
Feature mapping of the HLA class I region: localization of the POU5F1 and TCF19 genes. Genomics (1995) 0.82
In situ hybridization localizes the human OTF3 to chromosome 6p21.3-->p22 and OTF3L to 12p13. Cytogenet Cell Genet (1993) 0.82
Evaluation of 15 polymerases and phosphorothioate primer modification for detection of UV-induced C:G to T:A mutations by allele-specific PCR. Photochem Photobiol (2004) 0.80
Oct4 pseudogenes are transcribed in cancers. Biochem Biophys Res Commun (2005) 2.34
Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade. J Clin Invest (2009) 1.80
Improved neovascularization and wound repair by targeting human basic fibroblast growth factor (bFGF) to fibrin. J Mol Med (Berl) (2008) 1.46
NANOGP8 is a retrogene expressed in cancers. FEBS J (2006) 1.40
Alternative translation of OCT4 by an internal ribosome entry site and its novel function in stress response. Stem Cells (2009) 1.33
The enhancement of cancer stem cell properties of MCF-7 cells in 3D collagen scaffolds for modeling of cancer and anti-cancer drugs. Biomaterials (2011) 1.30
Three-dimensional graphene foam as a biocompatible and conductive scaffold for neural stem cells. Sci Rep (2013) 1.18
Expression of Nanog gene promotes NIH3T3 cell proliferation. Biochem Biophys Res Commun (2005) 1.16
L1 elements, processed pseudogenes and retrogenes in mammalian genomes. IUBMB Life (2006) 1.16
Mammalian target of rapamycin (mTOR) is involved in the neuronal differentiation of neural progenitors induced by insulin. Mol Cell Neurosci (2008) 1.12
Nogo-66 promotes the differentiation of neural progenitors into astroglial lineage cells through mTOR-STAT3 pathway. PLoS One (2008) 1.10
Homogeneous osteogenesis and bone regeneration by demineralized bone matrix loading with collagen-targeting bone morphogenetic protein-2. Biomaterials (2006) 1.07
The effect of crosslinking heparin to demineralized bone matrix on mechanical strength and specific binding to human bone morphogenetic protein-2. Biomaterials (2008) 1.04
Collagen-targeting vascular endothelial growth factor improves cardiac performance after myocardial infarction. Circulation (2009) 1.02
Controllable synthesis of monodispersed silver nanoparticles as standards for quantitative assessment of their cytotoxicity. Biomaterials (2011) 1.02
Transplantation of human mesenchymal stem cells loaded on collagen scaffolds for the treatment of traumatic brain injury in rats. Biomaterials (2013) 1.02
Direct conversion of fibroblasts into neural progenitor-like cells by forced growth into 3D spheres on low attachment surfaces. Biomaterials (2013) 1.01
The effect of collagen-binding NGF-beta on the promotion of sciatic nerve regeneration in a rat sciatic nerve crush injury model. Biomaterials (2009) 0.98
The novel OCT4 spliced variant OCT4B1 can generate three protein isoforms by alternative splicing into OCT4B. J Genet Genomics (2010) 0.98
Erk1/2 promotes proliferation and inhibits neuronal differentiation of neural stem cells. Neurosci Lett (2009) 0.97
The differentiation of rat adipose-derived stem cells into OEC-like cells on collagen scaffolds by co-culturing with OECs. Neurosci Lett (2007) 0.95
Linear ordered collagen scaffolds loaded with collagen-binding brain-derived neurotrophic factor improve the recovery of spinal cord injury in rats. Tissue Eng Part A (2009) 0.94
MiR-125b orchestrates cell proliferation, differentiation and migration in neural stem/progenitor cells by targeting Nestin. BMC Neurosci (2012) 0.93
Activation of demineralized bone matrix by genetically engineered human bone morphogenetic protein-2 with a collagen binding domain derived from von Willebrand factor propolypeptide. J Biomed Mater Res A (2007) 0.93
Acceleration of diabetic wound healing by collagen-binding vascular endothelial growth factor in diabetic rat model. Diabetes Res Clin Pract (2010) 0.93
Mannose selection system used for cucumber transformation. Plant Cell Rep (2006) 0.93
Stem-cell-capturing collagen scaffold promotes cardiac tissue regeneration. Biomaterials (2011) 0.92
The effect of forced growth of cells into 3D spheres using low attachment surfaces on the acquisition of stemness properties. Biomaterials (2013) 0.91
Maintenance of the self-renewal properties of neural progenitor cells cultured in three-dimensional collagen scaffolds by the REDD1-mTOR signal pathway. Biomaterials (2012) 0.91
The effect of collagen-targeting platelet-derived growth factor on cellularization and vascularization of collagen scaffolds. Biomaterials (2006) 0.91
The promotion of neurological recovery in the rat spinal cord crushed injury model by collagen-binding BDNF. Biomaterials (2010) 0.89
Crosslinked three-dimensional demineralized bone matrix for the adipose-derived stromal cell proliferation and differentiation. Tissue Eng Part A (2009) 0.89
Induction of rat facial nerve regeneration by functional collagen scaffolds. Biomaterials (2012) 0.89
The use of laminin modified linear ordered collagen scaffolds loaded with laminin-binding ciliary neurotrophic factor for sciatic nerve regeneration in rats. Biomaterials (2011) 0.89
Neuronal regeneration and protection by collagen-binding BDNF in the rat middle cerebral artery occlusion model. Biomaterials (2011) 0.89
The effect of collagen-binding vascular endothelial growth factor on the remodeling of scarred rat uterus following full-thickness injury. Biomaterials (2011) 0.88
The human pluripotency gene NANOG/NANOGP8 is expressed in gastric cancer and associated with tumor development. Oncol Lett (2010) 0.87
Improvement of sciatic nerve regeneration using laminin-binding human NGF-beta. PLoS One (2009) 0.87
Improved cellularization and angiogenesis using collagen scaffolds chemically conjugated with vascular endothelial growth factor. Acta Biomater (2010) 0.87
The three-dimensional collagen scaffold improves the stemness of rat bone marrow mesenchymal stem cells. J Genet Genomics (2012) 0.86
Linear ordered collagen scaffolds loaded with collagen-binding neurotrophin-3 promote axonal regeneration and partial functional recovery after complete spinal cord transection. J Neurotrauma (2010) 0.86
The promotion of cerebral ischemia recovery in rats by laminin-binding BDNF. Biomaterials (2011) 0.86
Magnetic resonance imaging of Fe3O4@SiO2-labeled human mesenchymal stem cells in mice at 11.7 T. Biomaterials (2013) 0.85
Collagen membranes loaded with collagen-binding human PDGF-BB accelerate wound healing in a rabbit dermal ischemic ulcer model. Growth Factors (2007) 0.85
The promotion of neural regeneration in an extreme rat spinal cord injury model using a collagen scaffold containing a collagen binding neuroprotective protein and an EGFR neutralizing antibody. Biomaterials (2010) 0.85
The novel function of OCT4B isoform-265 in genotoxic stress. Stem Cells (2012) 0.85
Crosslinking heparin to collagen scaffolds for the delivery of human platelet-derived growth factor. J Biomed Mater Res B Appl Biomater (2009) 0.84
Bladder regeneration by collagen scaffolds with collagen binding human basic fibroblast growth factor. J Urol (2010) 0.84
Novel nerve guidance material prepared from bovine aponeurosis. J Biomed Mater Res A (2006) 0.84
PEGylated graphene oxide-mediated protein delivery for cell function regulation. ACS Appl Mater Interfaces (2012) 0.84
The osteogenic effect of bone morphogenetic protein-2 on the collagen scaffold conjugated with antibodies. J Control Release (2009) 0.83
Nogo-66 regulates nanog expression through stat3 pathway in murine embryonic stem cells. Stem Cells Dev (2010) 0.83
Tetracycline inhibits local inflammation induced by cerebral ischemia via modulating autophagy. PLoS One (2012) 0.82
The miR-7 identified from collagen biomaterial-based three-dimensional cultured cells regulates neural stem cell differentiation. Stem Cells Dev (2013) 0.82
Effects of codon modification on human BMP2 gene expression in tobacco plants. Plant Cell Rep (2006) 0.82
Insulin rescues ES cell-derived neural progenitor cells from apoptosis by differential regulation of Akt and ERK pathways. Neurosci Lett (2007) 0.82
Loading of VEGF to the heparin cross-linked demineralized bone matrix improves vascularization of the scaffold. J Mater Sci Mater Med (2009) 0.82
Rotavirus capsid surface protein VP4-coated Fe(3)O(4) nanoparticles as a theranostic platform for cellular imaging and drug delivery. Biomaterials (2012) 0.82
Regeneration of uterine horns in rats by collagen scaffolds loaded with collagen-binding human basic fibroblast growth factor. Biomaterials (2011) 0.82
Vascularization and cellularization of collagen scaffolds incorporated with two different collagen-targeting human basic fibroblast growth factors. J Biomed Mater Res A (2007) 0.81
Direct chemical cross-linking of platelet-derived growth factor-BB to the demineralized bone matrix improves cellularization and vascularization. Biomacromolecules (2009) 0.81
Linear ordered collagen scaffolds loaded with collagen-binding basic fibroblast growth factor facilitate recovery of sciatic nerve injury in rats. Tissue Eng Part A (2014) 0.81
Neural regrowth induced by PLGA nerve conduits and neurotrophin-3 in rats with complete spinal cord transection. J Biomed Mater Res B Appl Biomater (2011) 0.81
3D bioprinting of BMSC-laden methacrylamide gelatin scaffolds with CBD-BMP2-collagen microfibers. Biofabrication (2015) 0.80
The bone-derived collagen containing mineralized matrix for the loading of collagen-binding bone morphogenetic protein-2. J Biomed Mater Res A (2009) 0.80
Mapping of the minimal internal ribosome entry site element in the human embryonic stem cell gene OCT4B mRNA. Biochem Biophys Res Commun (2010) 0.80
Collagen scaffolds loaded with collagen-binding NGF-beta accelerate ulcer healing. J Biomed Mater Res A (2010) 0.80
A myocardial patch made of collagen membranes loaded with collagen-binding human vascular endothelial growth factor accelerates healing of the injured rabbit heart. Tissue Eng Part A (2011) 0.80
Expression of active hBMP2 in transgenic tobacco plants. Plant Cell Rep (2006) 0.80
Promotion of peripheral nerve growth by collagen scaffolds loaded with collagen-targeting human nerve growth factor-beta. J Biomed Mater Res A (2007) 0.80
Collagen-binding human epidermal growth factor promotes cellularization of collagen scaffolds. Tissue Eng Part A (2009) 0.79
An in vitro study of a titanium surface modified by simvastatin-loaded titania nanotubes-micelles. J Biomed Nanotechnol (2014) 0.79
Single-molecule level binding force between collagen and collagen binding domain-growth factor conjugates. Biomaterials (2013) 0.79
Nerve regeneration and functional recovery by collagen-binding brain-derived neurotrophic factor in an intracerebral hemorrhage model. Tissue Eng Part A (2014) 0.79
Transplantation of human adipose-derived mesenchymal stem cells on a bladder acellular matrix for bladder regeneration in a canine model. Biomed Mater (2016) 0.79
Accelerating proliferation of neural stem/progenitor cells in collagen sponges immobilized with engineered basic fibroblast growth factor for nervous system tissue engineering. Biomacromolecules (2014) 0.79
Regeneration of uterine horns in rats using collagen scaffolds loaded with human embryonic stem cell-derived endometrium-like cells. Tissue Eng Part A (2014) 0.79
Phenotypical analysis of adult rat olfactory ensheathing cells on 3-D collagen scaffolds. Neurosci Lett (2006) 0.79
Effects of simvastatin-loaded polymeric micelles on human osteoblast-like MG-63 cells. Colloids Surf B Biointerfaces (2012) 0.78
Extrahepatic bile duct regeneration in pigs using collagen scaffolds loaded with human collagen-binding bFGF. Biomaterials (2012) 0.78
Effect of different regions of Nogo-A on the differentiation of neural progenitors. Neurosci Lett (2009) 0.78
Regeneration of full-thickness abdominal wall defects in rats using collagen scaffolds loaded with collagen-binding basic fibroblast growth factor. Biomaterials (2011) 0.77
Three-dimensional culture may promote cell reprogramming. Organogenesis (2013) 0.77
Promotion of diabetic wound healing by collagen scaffold with collagen-binding vascular endothelial growth factor in a diabetic rat model. J Tissue Eng Regen Med (2012) 0.77
Neoplastic transformation of human diploid fibroblasts after long-term serum starvation. Cancer Lett (2006) 0.77
Human basic fibroblast growth factor fused with Kringle4 peptide binds to a fibrin scaffold and enhances angiogenesis. Tissue Eng Part A (2009) 0.77
Effects of splice sites on the intron retention in histamine H3 receptors from rats and mice. J Genet Genomics (2009) 0.77
Clinical study of NeuroRegen scaffold combined with human mesenchymal stem cells for the repair of chronic complete spinal cord injury. Cell Transplant (2017) 0.76
Promotion of neuronal differentiation of neural progenitor cells by using EGFR antibody functionalized collagen scaffolds for spinal cord injury repair. Biomaterials (2013) 0.75
Evaluation of a bioactive bone-inducing material consisting of collagen scaffolds and collagen-binding bone morphogenetic protein 2. J Biomed Mater Res A (2013) 0.75
The effect of three-dimensional demineralized bone matrix on in vitro cumulus-free oocyte maturation. Biomaterials (2007) 0.75
[Effect of sustained-release basic fibroblast growth factor on healing of bile duct defect in pigs]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi (2013) 0.75
Repair of extrahepatic bile duct defect using a collagen patch in a Swine model. Artif Organs (2014) 0.75
Multiple sequence elements determine the intron retention in histamine H3 receptors in rats and mice. Int J Biochem Cell Biol (2009) 0.75
Methods for detecting transcribed pseudogenes: PCR on regions of high sequence similarity followed by cloning and sequencing. Methods Mol Biol (2014) 0.75
In vitro assessment of the dual-targeting behavior of a peptide-based magnetic resonance imaging contrast agent. Int J Mol Med (2013) 0.75
Collagen scaffolds combined with collagen-binding ciliary neurotrophic factor facilitate facial nerve repair in mini-pigs. J Biomed Mater Res A (2014) 0.75
Olfactory ensheathing cell apoptosis induced by hypoxia and serum deprivation. Neurosci Lett (2007) 0.75
Combining restriction digestion and touchdown PCR permits detection of trace isoforms of histamine H3 receptor. Biotechniques (2005) 0.75